For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Greater weight loss and more diabetes remission were seen among adult women with overweight, obesity, and T2D.

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

Shares in Danish pharmaceuticals giant Novo Nordisk (NOVO-B.CO, NVO) have continued to come under pressure amid competition in the weight-loss drug space, while UK health officials have launched a ...

In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

When you stop eating meat, you can experience short-term and long-term effects. Here's what happens to your body.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Glucotrack announced the results from its completed first-in-human clinical study of its implantable continuous glucose monitor (CGM) at the American Diabetes Association’s ...

Diabetes diagnoses are climbing, with about 37,000 adults diagnosed in Indiana every year, and doctors caution they are ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...